6Neutel J M, Smith D H G. For the Telmisartan US Study Group.Dose responseand antihypertensive efficacy of the AT1 receptor antagonist telmisartan inpatients with mild to moderate hypertension.Adv Ther, 1998,15: 206
7Oparil S, Dyke S, Houris F, et al. Valsartan: a randomized controlledtrial to compare the efficacy and safety of 20,80,160 and 320mg with placeboin the management of essential hypertension.Clin Ther,1996,18(5):797
8Kulbertus H Pharma-clinics medication of the month. Telmisartan (Micardis) . Rev Med Liege, 2000,55(3):200(Abstract)
9Markham A, Goa K L. Valsartan: a review of its pharmacology andtherapeutic use in essential hypertension. Drug, 1997,54:299
10Ruilope L M, Aldigier J C, Ponticelli C, et al. Safety of thecombination of valsartan and benazepril in patients with chronic renaldisease. J Hypertens,2000,18(1):89
二级参考文献87
1[1]Taavitsainen P, Kiukaanniemi K, Pelkonen O. In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin- II receptor antagonists [ J ]. Eur-J-Chin-Pharmacol, 2000, 56 ( 2 ):135-40
2[2]Weber MA, Byyny RL, Pratt JH, et al. Blood pressure effects of the angiotensin Ⅱ receptor blocker, losartan[J]. Arch Intern Med,1995, 155:405-411
3[3]Mallion JM. Antihypertensive efficacy and tolerability of once daily losartan compared with captopril in patients with mild to moderate essential hypertension[J]. J Hypertens, 1995, 13(Suppl): S35-S41
4[4]Chan JC, Critchley JA, Lappe JT, et al. Randomized double -blind parallel study of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension [ J ]. J Hum Hypertens, 1995, 9:765-771
5[5]Crozier I, Ikram H, Awan N, et al. Losartan in heart failure:hemodynamic effects and tolerability[ J ]. Circulation, 91 (3):691-697
6[6]Toto R. Angiotensin II subtype 1 receptor blockers and renal function[J]. Arch Intern Med, 2001, 161(12):1492-9
7[7]Monterroso VH, Rodriguez- Chavez V, Carbajal ET et al. Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin Ⅱ receptor antagonists, losartan and valsartan[J]. Adv Ther, 2000, 17(2): 117-31
8[8]Oparil S, Barr E, Elkins M, et al. Efficacy, tolersbility, and effects on quality of life of losartan, alone or with hydrochlorothiazide,versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension[J]. Clin Ther, 1996, 18(4):608-625
9[9]Cha YJ, Pearson VE. Angioedema due to losartan[J]. Ann Pharmacother, 1999,33(9) :936-8
10[10]Tikkanen I, Omvik P, Jensen HA for the Scandinavian Study Group. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension[J]. J Hypertens. 1995,13:1343-1351
2Ruiz Ortega M,Egido J. Angiotens in Ⅱ modulates cell growth related events and synthesis of matrix proteins in renal interstitial fibroblasts[J].{H}Kidney International,1997.1497-1510.
